全PPAR激动剂贝扎菲布拉特通过抑制LCN2依赖性铁灭菌来缓解牛皮
Rujuan Xin1, Jianbin Zhang2, Yixin Zhang3
1Department of Pharmacy, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China; Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Free radical biology & medicine
|February 9, 2026
概括
贝扎纤维酸 (BEZ) 治疗可通过抑制细胞死亡途径铁亡,并重编程脂质代谢来缓解牛皮. 这通过抑制Lipocalin-2 (LCN2) 来实现,为炎症性皮肤疾病提供了一种新的治疗策略.
科学领域:
- 皮肤病学 皮肤病学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 牛皮是一种慢性炎症性皮肤疾病,涉及状细胞的过度增殖和免疫失调.
- 铁,一种由脂质过氧化驱动的依赖铁的细胞死亡途径,越来越被认为是牛皮的关键因素.
- 卡林-2 (LCN2),一种铁结合蛋白在牛皮中高,可能在与铁死相关的病原发生中发挥作用.
研究的目的:
- 通过LCN2介导的机制来向铁化,研究一个泛酶增殖器激活受体 (PPAR) 激素Besafibrate (BEZ) 是否可以改善牛皮.
- 在牛皮病模型中探索BEZ对铁亡标记物,脂质代谢和炎症途径的影响.
主要方法:
- 在牛皮病变和伊米基莫德 (IMQ) 诱导的小鼠模型中分析铁亡标记物 (GPX4,ACSL4,ALOX12,脂质过氧化,GSH).
- 评估BEZ治疗对疾病严重程度,表皮厚度和角质细胞增殖的影响.
- 脂质组和途径分析以确定BEZ调节的脂类物种和代谢途径.
- 研究LCN2在BEZ治疗效果中的作用,使用LCN2过度表达的角质细胞培养物.
主要成果:
- 牛皮病变显示出显著的铁灭激活,包括减少GPX4和谷氨 (GSH),增加ACSL4,ALOX12和脂质过氧化.
- BEZ治疗显著降低了牛皮的严重程度,表皮厚度和角质细胞的增殖,同时恢复了氧化还原平衡.
- 贝兹逆转了IMQ诱导的pro-ferroptotic脂质的积累,调节了阿拉基酸代谢,增强了保护性以太和脂路径.
- 贝兹抑制了LCN2的表达,而LCN2的过度表达抵消了贝兹对铁和炎症的保护作用.
结论:
- 贝兹通过抑制铁和重编程脂质代谢,有效地缓解牛皮.
- 贝兹的治疗效果部分通过抑制LCN2.2进行介导.
- 全PPAR激活代表了一种有前途的多方面的治疗策略,用于皮肤炎症疾病,如牛皮.
相关概念视频
Adrenergic Agonists: Therapeutic Uses
2.0K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
Glucagon-like Receptor Agonists
1.0K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.0K
Frequency-dependent Selection
24.2K
When the fitness of a trait is influenced by how common it is (i.e., its frequency) relative to different traits within a population, this is referred to as frequency-dependent selection. Frequency-dependent selection may occur between species or within a single species. This type of selection can either be positive—with more common phenotypes having higher fitness—or negative, with rarer phenotypes conferring increased fitness.
24.2K
Drug-Receptor Interaction: Agonist
4.1K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.1K
Adrenergic Agonists: Therapeutic Classification
1.7K
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
1.7K
Drug Dependence
1.7K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.7K


